LASA Supergenerics reported a Q1 net loss of ₹8.26 Cr. Operations ceased after a factory fire caused an uninsured exceptional loss of ₹20.57 Cr. The company, unable to restart manufacturing, is exploring contract production or leasing facilities amidst going concern uncertainty.